| 5/1/2026 | Keefe, Bruyette & Woods | Boost Target | Outperform ➝ Outperform | $18.00 ➝ $18.50 | |
| 5/1/2026 | Citizens Jmp | Boost Target | Market Outperform ➝ Market Outperform | $21.00 ➝ $22.00 | |
| 4/21/2026 | Weiss Ratings | Reiterated Rating | Hold (C) ➝ Hold (C) | | |
| 3/13/2026 | Barclays | Lower Target | Overweight ➝ Overweight | $21.00 ➝ $19.00 | |
| 3/2/2026 | Keefe, Bruyette & Woods | Lower Target | Outperform ➝ Outperform | $22.00 ➝ $18.00 | |
| 1/22/2026 | Weiss Ratings | Reiterated Rating | Hold (C) ➝ Hold (C) | | |
| 1/8/2026 | Keefe, Bruyette & Woods | Boost Target | Outperform ➝ Outperform | $21.00 ➝ $22.00 | |
| 12/18/2025 | Citigroup | Reiterated Rating | Market Outperform ➝ Market Outperform | | |
| 12/2/2025 | Barclays | Initiated Coverage | Overweight | $21.00 | |
| 10/9/2025 | Keefe, Bruyette & Woods | Boost Target | Outperform ➝ Outperform | $18.00 ➝ $21.00 | |
| 10/8/2025 | Weiss Ratings | Reiterated Rating | Hold (C) ➝ Hold (C) | | |
| 10/2/2025 | Zacks Research | Downgrade | Strong-Buy ➝ Hold | | |
| 9/27/2025 | Weiss Ratings | Reiterated Rating | Hold (C) ➝ Hold (C) | | |
| 8/4/2025 | Piper Sandler | Boost Target | Overweight ➝ Overweight | $16.00 ➝ $19.00 | |
| 7/31/2025 | Citizens Jmp | Boost Target | Market Outperform ➝ Market Outperform | $17.00 ➝ $19.00 | |
| 7/24/2025 | Keefe, Bruyette & Woods | Boost Target | Outperform ➝ Outperform | $14.00 ➝ $15.00 | |
| 7/21/2025 | Citizens Jmp | Initiated Coverage | Market Outperform | $17.00 | |
| 5/23/2025 | Wolfe Research | Upgrade | Peer Perform ➝ Outperform | $14.00 | |
| 5/5/2025 | Piper Sandler | Lower Target | Overweight ➝ Overweight | $19.00 ➝ $16.00 | |
| 5/2/2025 | Keefe, Bruyette & Woods | Lower Target | Outperform ➝ Outperform | $14.50 ➝ $14.00 | |
| 4/17/2025 | Keefe, Bruyette & Woods | Lower Target | Outperform ➝ Outperform | $18.00 ➝ $14.50 | |
| 3/19/2025 | The Goldman Sachs Group | Lower Target | Buy ➝ Buy | $19.50 ➝ $17.00 | |
| 12/6/2024 | The Goldman Sachs Group | Initiated Coverage | Buy | $19.00 | |
| 11/25/2024 | Wolfe Research | Downgrade | Outperform ➝ Peer Perform | | |
| 9/5/2024 | Keefe, Bruyette & Woods | Upgrade | Market Perform ➝ Outperform | $13.50 ➝ $16.50 | |
| 9/3/2024 | Piper Sandler | Boost Target | Overweight ➝ Overweight | $13.00 ➝ $17.00 | |
| 8/16/2024 | Wolfe Research | Upgrade | Peer Perform ➝ Outperform | $15.00 | |
| 8/8/2024 | Keefe, Bruyette & Woods | Boost Target | Market Perform ➝ Market Perform | $13.00 ➝ $13.50 | |
| 7/25/2024 | Keefe, Bruyette & Woods | Boost Target | Market Perform ➝ Market Perform | $11.25 ➝ $13.00 | |
| 3/26/2024 | Piper Sandler | Reiterated Rating | Overweight ➝ Overweight | $13.00 | |
| 2/26/2024 | Keefe, Bruyette & Woods | Boost Target | Market Perform ➝ Market Perform | $11.00 ➝ $11.25 | |
| 12/20/2023 | Piper Sandler | Upgrade | Neutral ➝ Overweight | $7.00 ➝ $13.00 | |
| 10/4/2023 | Raymond James Financial | Downgrade | Outperform ➝ Market Perform | | |
| 10/3/2023 | Keefe, Bruyette & Woods | Lower Target | | $7.50 ➝ $7.00 | |
| 5/8/2023 | Piper Sandler | Lower Target | | $9.00 ➝ $6.50 | |
| 4/10/2023 | The Goldman Sachs Group | Lower Target | Sell | $9.00 ➝ $6.25 | |
| 2/17/2023 | The Goldman Sachs Group | Boost Target | Sell | $8.00 ➝ $9.00 | |
| 1/20/2023 | Raymond James Financial | Lower Target | Outperform | $13.00 ➝ $10.00 | |
| 12/12/2022 | The Goldman Sachs Group | Downgrade | Neutral ➝ Sell | $9.00 ➝ $8.00 | |
| 11/8/2022 | The Goldman Sachs Group | Lower Target | Neutral | $10.25 ➝ $9.00 | |
| 10/31/2022 | Raymond James Financial | Lower Target | Outperform | $15.00 ➝ $13.00 | |
| 10/20/2022 | Raymond James Financial | Lower Target | Outperform | $16.00 ➝ $15.00 | |
| 10/19/2022 | The Goldman Sachs Group | Lower Target | Neutral | $13.25 ➝ $10.25 | |
| 10/13/2022 | Piper Sandler | Lower Target | | $10.00 | |
| 10/7/2022 | Piper Sandler | Lower Target | Neutral | $12.00 ➝ $10.00 | |
| 7/4/2022 | Piper Sandler | Lower Target | | $11.00 | |
| 4/26/2022 | Raymond James Financial | Lower Target | Outperform | $21.00 ➝ $18.00 | |
| 4/18/2022 | Piper Sandler | Downgrade | Overweight ➝ Neutral | $20.00 ➝ $15.00 | |
| 4/5/2022 | The Goldman Sachs Group | Initiated Coverage | Neutral | $18.00 | |
| 3/10/2022 | Wolfe Research | Downgrade | Outperform ➝ Peer Perform | $22.00 ➝ $17.00 | |
| 11/8/2021 | Raymond James Financial | Boost Target | Outperform | $20.00 ➝ $21.00 | |
| 8/9/2021 | Raymond James Financial | Boost Target | Outperform | $18.00 ➝ $20.00 | |
| 6/14/2021 | Wolfe Research | Initiated Coverage | Outperform | $22.00 | |